BioSense 2.0: Public Health Surveillance Through Collaboration. Monday Biosecurity Meeting: Crowd-Sourcing for Outbreak and Agent Identification, The American Association for the Advancement of Science (AAAS) Center for Science, Technology, and Security Policy. Presented by Taha Kass-Hout, MD, MS on November 21, 2011, Noon-1:30pm, Abelson/Haskins Room (2nd Floor, AAAS, 1200 New York Avenue, NW, Washington, DC 20005)
Glomerular Filtration and determinants of glomerular filtration .pptx
Public Health Surveillance Through Collaboration
1. BioSense 2.0
Public Health Surveillance Through Collaboration
Monday Biosecurity Meeting: Crowd-Sourcing for Outbreak and Agent Identification
The American Association for the Advancement of Science (AAAS) Center for Science, Technology, and Security Policy
November 21, 2011, Noon-1:30pm
Abelson/Haskins Room (2nd Floor, AAAS, 1200 New York Avenue, NW, Washington, DC 20005)
Taha A. Kass-Hout, MD, MS
Deputy Director for Information Science and BioSense Program Manager
Division of Notifiable Diseases and Healthcare Information (DNDHI, Proposed)
Public Health Surveillance and Informatics Program Office (PHSIPO, Proposed)
Office of Surveillance, Epidemiology, and Laboratory Services (OSELS)
Centers for Disease Control & Prevention (CDC)
Any views or opinions expressed here do not necessarily represent the views of the CDC, HHS, or any other entity of the United States
government. Furthermore, the use of any product names, trade names, images, or commercial sources is for identification purposes only,
and does not imply endorsement or government sanction by the U.S. Department of Health and Human Services.
Office of Surveillance, Epidemiology, and Laboratory Services
Public Health Surveillance and Informatics Program Office (Proposed)
4. Shift in Business Model
From Need-to-Know (1.0) to Need-to-Co Create (2.0)
Crowd of people Community of kindred spirits
Anyone can Join
Openness
Selection Process
Club of experts Coalition of Parties
Initiator Only Ownership Initiator And
Contributors
Adopted from Fronteer Strategy, 2009
5. Shift in Business Model
From Need-to-Know (1.0) to Need-to-Co Create (2.0)
Crowd of people Community of kindred spirits
Anyone can Join
Public-Access
Openness BioSense 2.0
Restricted-Access
Selection Process BioSense 1.0
Club of experts Coalition of Parties
Initiator Only Ownership Initiator And
Contributors
Adopted from Fronteer Strategy, 2009
7. Thank You!
BioSense 2.0
http://biosenseredesign.org
info@biosen.se
Any views or opinions expressed here do not necessarily represent the views of the CDC, HHS, or any other entity of the United States
government. Furthermore, the use of any product names, trade names, images, or commercial sources is for identification purposes only,
and does not imply endorsement or government sanction by the U.S. Department of Health and Human Services.
Hinweis der Redaktion
As mandated in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 in response to the September 11 and anthrax attacks, CDC’s BioSense program was launched in 2003 with the aim of establishing an “integrated system” of nationwide “biosurveillance” for early detection and prompt assessment of potential bioterrorism-related illness.
Each jurisdictions (state, county, or city) will have its own space that it can control fully and decides what to share, at what level (aggregate or detailed), when, and with whom in the collaboration spaces. There is also an option for public-access sharing of data.One example, neighboring jurisdictions want to consistently share data with one another (e.g., Boston and NYC). Another relationship would be sharing for a limited time period, such as during sport events. Boston; for example, might want to share data with Houston surrounding a basketball game where Houston fans flew to Boston to support their team and got sick. In a third example, multiple jurisdictions at multiple levels want to share information with one another to create a larger regional or national picture of a public health scenario, for example, Influenza. With the permission of the jurisdictions involved, CDC can be invited to have access to this data in the collaborative environment. With the new approach of BioSense 2.0, it will allow the health departments to stitch a much more complete and accurate regional and national picture of a variety of illness and injury.